Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.